Iovance Biotherapeutics, Inc.
2019 Q4 - 2025 Q4 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 637 | 0.0% | 231,443 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 471 | 0.0% | 273,986 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 905 | 0.0% | 271,826 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 2,069 | 0.0% | 279,627 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 2,929 | 0.0% | 311,907 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 2,691 | 0.0% | 335,513 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 5,320 | 0.0% | 358,988 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 2,154 | 0.0% | 264,971 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 1,201 | 0.0% | 263,929 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,555 | 0.0% | 220,852 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 1,006 | 0.0% | 164,687 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 1,031 | 0.0% | 163,247 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 1,526 | 0.0% | 159,821 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 1,764 | 0.0% | 161,200 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 1,725 | 0.0% | 103,303 | 3/31/2022 |
| 2020 Q1 | 5/15/2020 | 2,130 | 0.0% | 71,140 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,819 | 0.0% | 65,705 | 12/31/2019 |